Xos, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Xos, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.99M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $55.96M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $44.52M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $36.38M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $5.05M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.64M | Mar 30, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.72M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $3.97M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($1.29M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($30.03M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($2.36M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $300.0K | Mar 30, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($25.32M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($50.16M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($75.84M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($73.33M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $23.40M | Mar 31, 2023 |
| FY2020 | Dec 31, 2020 | ($6.67M) | May 14, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($33.08M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($45.87M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($64.97M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($111.35M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($53.16M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($11.87M) | Mar 30, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.00M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $10.63M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $19.59M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $30.68M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $20.08M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $7.02M | Mar 30, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.37M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($48.80M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($39.29M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($127.96M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($88.90M) | Mar 31, 2023 |
| FY2020 | Dec 31, 2020 | ($725.9K) | May 14, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $304.0K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $1.39M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $14.11M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $4.92M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $407.0K | Mar 30, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.36M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $98.33M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $93.68M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $189.94M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $228.71M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $13.77M | Mar 30, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.08M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $64.72M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $48.49M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $77.86M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $54.31M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $33.11M | Mar 30, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.29M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $33.61M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $45.20M | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | $112.08M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $174.39M | Mar 29, 2024 |
| FY2022 | Dec 31, 2020 | ($27.20M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | ($10.53M) | Mar 30, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($228.74M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($203.42M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($153.26M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($77.42M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($4.09M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($27.49M) | Mar 30, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.04M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $11.00M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $11.64M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $35.63M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $16.14M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $10.36M | Mar 30, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | (6) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | (13) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (13) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 30, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | (6) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | (13) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (13) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 30, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11.40M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 8.05M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 5.94M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 5.63M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 163.14M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 72.28M | Mar 30, 2022 |